Back to Companies
Turn Therapeutics Inc.
TTRXNasdaqCIK: 0002023016
Over the 29 most recent insider filings, Turn Therapeutics Inc. (TTRX) has seen activity from 8 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $249.5K bought versus $0 sold, a net purchase of $249.5K. Chaudhary Zuraiz (See Remarks) is the most active by dollar volume, and the single largest transaction was $2.4M by Chaudhary Zuraiz. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$5.4M
Purchases
$249.5K
Sales
$0
Unique Insiders
8
Recent Insider Trades
29 loaded
| Jun 8 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Award | $546.3K |
| Jun 8 | TTRX Turn Therapeutics Inc. | Kester Kent Edward | Director | Award | $479.2K |
| Jun 8 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Award | $515.1K |
| Jun 8 | TTRX Turn Therapeutics Inc. | Dewhurst Martin William | Director | Award | $412.1K |
| Jun 1 | TTRX Turn Therapeutics Inc. | Burnam Bradley Evan | Chief Executive Officer, Director, 10% Owner | Gift | $0 |
| Apr 3 | TTRX Turn Therapeutics Inc. | Burnam Bradley Evan | Chief Executive Officer, Director, 10% Owner | Gift | $0 |
| Apr 3 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Gift | $0 |
| Apr 3 | TTRX Turn Therapeutics Inc. | Burnam Bradley Evan | Chief Executive Officer, Director, 10% Owner | Award | $548.8K |
| Apr 3 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Award | $249.6K |
| Feb 4 | TTRX Turn Therapeutics Inc. | Dewhurst Martin William | Director | Grant | $0 |
| Feb 4 | TTRX Turn Therapeutics Inc. | Dewhurst Martin William | Director | Other | $0 |
| Dec 12 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Buy | $8.8K |
| Nov 25 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Buy | $33.9K |
| Nov 21 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Buy | $7.1K |
| Nov 17 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Buy | $9.1K |
| Oct 23 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Buy | $100.0K |
| Oct 29 | TTRX Turn Therapeutics Inc. | Chesed Abraham | Insider | Buy | $65.7K |
| Oct 23 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Buy | $25.0K |
| Oct 10 | TTRX Turn Therapeutics Inc. | Ghodadra Neilesh Shailesh | Chief Medical Officer, Director | Grant | $0 |
| Oct 10 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Grant | $0 |
| Oct 10 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Grant | $0 |
| Oct 10 | TTRX Turn Therapeutics Inc. | Kester Kent Edward | Director | Grant | $0 |
| Oct 10 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Award | $2.4M |
| Oct 7 | TTRX Turn Therapeutics Inc. | Chaudhary Zuraiz | See Remarks | Other | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | Burnam Bradley Evan | Chief Executive Officer, Director, 10% Owner | Other | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | Kester Kent Edward | Director | Other | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | GOLDEN ARTHUR F | Director | Other | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | Gengos Andrew | Director | Other | $0 |
| Oct 7 | TTRX Turn Therapeutics Inc. | Ghodadra Neilesh Shailesh | Chief Medical Officer, Director | Other | $0 |
29 filings